It is unsettling when tests done on the same body seem to tell different stories. A CT scan may describe several nodules along the outer wall of the bowel, while repeated biopsies find no cancer cells and an MRI shows nothing definite. When a person had cancer surgery elsewhere years ago, clinicians naturally consider recurrence or spread first, leaving families asking how something can be called cancer when the reports say normal. This mismatch is usually not an error; different tests simply see different things.
It helps to know what a normal biopsy report actually claims. Pathology does not say there is no cancer anywhere in the body. It says that in this particular piece of tissue, no malignant cells were identified. A needle may have passed just beside the lesion, the sample may have been too small, it may have captured only fibrosis or dead tissue at the surface, or inflammation may have altered the cells. This is called a false negative, and it is why a negative biopsy alone does not close the question.
The route of sampling matters just as much. A biopsy taken during colonoscopy removes tissue from the inner lining of the bowel. A lesion pressing in from the outer wall or from the peritoneum, the membrane lining the abdominal cavity, can leave that inner lining looking healthy. In that situation other approaches are discussed: an image-guided needle biopsy performed under CT or ultrasound, a diagnostic laparoscopy in which small incisions allow the peritoneal surfaces to be seen and sampled directly, or peritoneal washing cytology, in which fluid rinsed through the abdomen is examined for cells.
Imaging tests can also disagree with each other for understandable reasons. CT, MRI, and PET-CT measure density, tissue and water characteristics, and glucose metabolism respectively. Thin sheets of disease spread across the peritoneum may be hard to see depending on the region scanned and the contrast technique used. Very small deposits, mucinous tumors, and diffuse patterns such as signet ring cell carcinoma may take up relatively little tracer on PET-CT. Conversely, tuberculous peritonitis, inflammation, adhesions, post-surgical change, fat necrosis, and less common tumors can mimic metastatic nodules on imaging. Neither imaging alone nor a single negative biopsy settles the matter.
Linking current findings to a cancer treated long ago is often possible. Paraffin blocks or slides stored at the original hospital can be borrowed and compared with new tissue, and immunohistochemical staining can suggest where the cells originated. That comparison helps distinguish a new primary cancer from recurrence of the earlier one.
A few questions make the conversation more productive: exactly where the suspected lesions are, whether previous biopsies reached that location, what sampling methods remain and what risks each carries, whether any treatment can begin without tissue confirmation, and when repeat imaging should be scheduled while waiting. Listing test dates and results in chronological order on a single page helps convey the sequence during a short appointment. Seek care immediately, without waiting for a scheduled visit, if there is repeated vomiting with abdominal distension and no passage of stool or gas, sudden severe abdominal pain, or fever.
This article is general information and does not replace individual diagnosis or medical care. Interpretation of results and the next steps depend on personal history and condition, so please discuss them with your own medical team.